Chagas disease is caused by a parasite and can cause serious heart and stomach problems.

ME, C., TM, C., JLN, S., JBDR, R., IB, D., FBR, O., M, R., LLO, S., LF, S., LP, S., CCO, A., AR, A., IDS, O., AL, G. d. O., LVBD, A., GGM, L., GMES, J., ILS, M., MPD, R., GD, C., A, S., LMD, M., LL, B., FS, M., & RT, F. (2026). IL-33/ST2 Signaling Protects the Heart by Restraining Inflammation and Parasite Burden during <i>Trypanosoma cruzi</i> Experimental Infection.. doi.org. https://doi.org/10.1021/acsinfecdis.5c00859

MJ, O., A, A., & AM, H. (2026). Long-Term Parasitological Clearance and Cardiac Progression in <i>Trypanosoma cruzi</i> TcI: A Phase-Stratified Cohort from Colombia.. doi.org. https://doi.org/10.3390/tropicalmed11020059

AC, I., CKV, N., PS, D., CM, A., BC, B., GB, C., JF, V., BSF, S., SG, M., & MBP, S. (2025). Exercise training reduces cardiac fibrosis, promoting improvement in arrhythmias and cardiac dysfunction in an experimental model of chronic chagasic cardiomyopathy.. doi.org. https://doi.org/10.3389/fphys.2025.1558678

FB, G., B, D., W, S., OA, B., & AR, P. (2025). Bridging the Nervous-Endocrine System and Immune Response, in Human Chagas Disease Pathology.. doi.org. https://doi.org/10.1159/000548813

TBS, P., ALP, F., DD, S., LDD, F., CELF, P., LCM, V., IC, S., & FLN, S. (2026). A retrospective study on Chagas disease detection and management in Tremedal and Novo Horizonte: Insights prior to the Oxente Chagas Bahia Project.. doi.org. https://doi.org/10.1371/journal.pntd.0014569

AC, F., GJ, B., R, A., & J, F. T. (2026). Trypanosoma cruzi Cardiomyopathy Diagnosed via Explant Tissue 28S Ribosomal Gene Sequencing Following Orthotopic Heart Transplantation.. doi.org. https://doi.org/10.7759/cureus.112969

WMD, S., TSF, A., JB, C. N., H, O., MM, T., GABD, S., RC, S., D, C. F., V, R. J., LH, F., & AP, R. (2026). Effects of MK-886, an inhibitor of the 5-lipoxygenase-activating protein, on peripheral blood mononuclear cells from patients with Chagas' heart disease.. doi.org. https://doi.org/10.1590/0037-8682-0130-2026

LA, D. J., I, M., J, P., M, S., & B, E. (2026). Stage-Informed <i>Trypanosoma cruzi</i> Antigen Selection Enhances Assay Concordance in the Evaluation of Discordant Chagas Disease Serology.. doi.org. https://doi.org/10.3390/microorganisms14091899

JP, R., HT, A., VV, B., & ALF, C. (2026). Neurochagas: Experimental and human literature of an uncommon entity (Review).. doi.org. https://doi.org/10.3892/mi.2026.320

AM, H., ACR, R., ARD, C., AS, S., FSNS, M., FM, C., F, M., GMSD, S., HH, V., LF, P., LHC, S., MT, H., PS, d. S., RM, S., SS, X., & MFF, M. (2025). Clinical Protocols for the Initial Evaluation and Follow-Up of Patients with Chronic Chagas Disease: A Proposal for Referral Centers.. doi.org. https://doi.org/10.3390/tropicalmed11010003

E, D. & C, H. (2026). Epitope mapping of vaccine antigens Tc24 and TSA1 with antibodies from Trypanosoma cruzi-infected patients.. doi.org. https://doi.org/10.1038/s41435-026-00380-8